Last updated: July 18, 2024
Sponsor: Montefiore Medical Center
Overall Status: Suspended
Phase
3
Condition
Glaucoma
Treatment
Pilocarpine
Ofloxacin
Prednisolone
Clinical Study ID
NCT03933631
2018-9829
Ages 30-100 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients with ocular hypertension or open angle glaucoma undergoing combinedcataract surgery with KDB
Exclusion
Exclusion Criteria:
- Patients with previous history of eye surgeries (including laser procedures)
Study Design
Total Participants: 142
Treatment Group(s): 3
Primary Treatment: Pilocarpine
Phase: 3
Study Start date:
May 01, 2019
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
Montefiore Medical Center
Bronx, New York 10467
United StatesSite Not Available
Montefiore Wakefield Campus
Bronx, New York 10466
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.